Recent Results in Cancer Research

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Editors: Ignatiadis, Michail, Sotiriou, Christos, Pantel, Klaus (Eds.)

  • Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients
  • Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)
  • Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers
see more benefits

Buy this book

eBook $179.00
price for USA (gross)
  • ISBN 978-3-642-28160-0
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $229.00
price for USA
  • ISBN 978-3-642-28159-4
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $229.00
price for USA
  • ISBN 978-3-642-44587-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
About this book

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.

Reviews

From the reviews:

“This book is aimed directly at cancer researchers, delving into the various technologies used to identify and characterize these rare tumor cells. … this is the first book to summarize the progress in this field. It charts the evolution in thinking about breast cancer from the Halstedian notion of a local disease to more of a systemic illness in an accessible way and nicely summarizes the data without overwhelming readers.” (Megan E. Sullivan, Doody’s Review Service, July, 2012)


Table of contents (22 chapters)

  • Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer: Open Questions for Research

    Ignatiadis, Michail (et al.)

    Pages 3-9

  • Self-Seeding in Cancer

    Comen, Elizabeth (et al.)

    Pages 13-23

  • Microenvironments Dictating Tumor Cell Dormancy

    Bragado, Paloma (et al.)

    Pages 25-39

  • Immunomagnetic Separation Technologies

    Hoeppener, Astrid E. L. M. (et al.)

    Pages 43-58

  • Microfluidic Technologies

    Bhagat, Ali Asgar. S. (et al.)

    Pages 59-67

Buy this book

eBook $179.00
price for USA (gross)
  • ISBN 978-3-642-28160-0
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $229.00
price for USA
  • ISBN 978-3-642-28159-4
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $229.00
price for USA
  • ISBN 978-3-642-44587-3
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Editors
  • Michail Ignatiadis
  • Christos Sotiriou
  • Klaus Pantel
Series Title
Recent Results in Cancer Research
Series Volume
195
Copyright
2012
Publisher
Springer-Verlag Berlin Heidelberg
Copyright Holder
Springer-Verlag Berlin Heidelberg
eBook ISBN
978-3-642-28160-0
DOI
10.1007/978-3-642-28160-0
Hardcover ISBN
978-3-642-28159-4
Softcover ISBN
978-3-642-44587-3
Series ISSN
0080-0015
Edition Number
1
Number of Pages
XIV, 254
Topics